Alterations of the redox state, pentose pathway and glutathione metabolism in an acute porphyria model. their impact on heme pathway

Experimental Biology and Medicine

Volumn 238, Issue 2, 2013, Pages 133-143

  Faut, Mónica ^a   Paiz, Andrea ^a   de Viale, Leonor C San Martín ^a   Mazzetti, Marta B ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Glucose 6 phosphate dehydrogenase; Glutathione metabolism; Pentose phosphate pathway; Porphyria; Rat liver; Reactive oxygen species

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HEME; PHOSPHOGLUCONATE DEHYDROGENASE; PYRIDINE NUCLEOTIDE; REACTIVE OXYGEN METABOLITE;

ACUTE INTERMITTENT PORPHYRIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA DAMAGE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTATHIONE METABOLISM; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PENTOSE PHOSPHATE CYCLE; PROTEIN DETERMINATION; RAT; SPECTROPHOTOMETRY; URINALYSIS;

ALLYLISOPROPYLACETAMIDE; ANIMALS; DISEASE MODELS, ANIMAL; GLUCOSE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HEME; LIVER; NADP; OXIDATION-REDUCTION; OXIDATIVE STRESS; PENTOSE PHOSPHATE PATHWAY; PORPHYRIA, ACUTE INTERMITTENT; PYRIDINES; RATS; REACTIVE OXYGEN SPECIES;

EID: 84877661190     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370212473702     Document Type: Article

References (50)

1. Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyries. In: Scriver CR, Beaudet AL, Sly WS, et al., eds. Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill, 1995:2103-59.
2. Smith AG, De Matteis F. Drugs and the hepatic porphyrias. Clin Haematol 1980;9:399-425.
3. Marks GS, McCluskey SA, Mackie JE, Riddick DS, James CA. Disruption of hepatic heme biosynthesis after interaction of xenobiotics with cytochrome P-450. FASEB J 1988;2:2774-783.
4. Lelli SM, San Martin de Viale LC, Mazzetti MB. Response of glucose metabolism enzymes in an acute porphyria model. Role of reactive oxygen species. Toxicology 2005;216:49-58.
5. Rocha ME, Dutra F, Bandy B, Baldini RL, Gomes SL, Faljoni-Alario A, Liria CW, Miranda MT, Bechara EJ. Oxidative damage to ferritin by 5-aminolevulinic acid. Arch Biochem Biophys 2003;409:349-56.
6. Monteiro HP, Abdalla DSP, Augusto O, Bechara EJH. Free radical generation during delta-aminolevulinic acid autoxidation: induction by hemoglobin and connections with porphyrinpathies. Arch Biochem Biophys 1989;271:206-16.
7. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. 3rd edn. London: Oxford University Press, 1999:450-622.
8. Rose JA, Hellman ES, Tschudy DP. Effect on diet on induction of experimental porphyria. Metabolism 1961;10:514-21.
9. Tschudy DP, Welland FH, Collins A, Hunter G Jr. The effect of carbohydrate feeding on the induction of delta-aminolevulinic acid synthetase. Metabolism 1964;13:396-406.
10. Matkovic LB, D'Andrea F, Fornes D, San Marti{dotless}́n de Viale LC, Mazzetti MB. How porphyrinogenic drugs modeling acute porphyria impair the hormonal status that regulates glucose metabolism. Their relevance in the onset of this disease. Toxicology 2011;290:22-30.
11. Berg JM, Stryer L, Tymoczko JL. Biochemistry. 6th edn. New York: Freeman and Co, 2007.
12. Spolarics Z. Endotoxemia, pentose cycle, and the oxidant/antioxidant balance in the hepatic sinusoid. J Leukoc Biol 1998;63:534-41.
13. Pompella A, Visvikis A, Paolicchi A, De Tata V, Casini AF. The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol 2003;66:1499-503.
14. Pastore A, Piemonte F, Locatelli M, Lo Russo A, Gaeta LM, Tozzi G, Federici G. Determination of blood total, reduced, and oxidized glutathione in pediatric subjects. Clin Chem 2001;47:1467-9.
15. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600.
16. Higgins LG, Hayes JD. Mechanisms of induction of cytosolic and microsomal glutathione transferase (GST) genes by xenobiotics and pro-inflammatory agents. Drug Metab Rev 2011;43:92-137.
17. Ahmad H, Singh S, Awasthi YC. Inhibition of bovine lens glutathione S-transferases by hematin, bilirubin, and bromosulfophthalein. Lens Eye Toxic Res 1991;8:431-40.
18. Aniya Y, Anders MW. Alteration of hepatic glutathione S-transferases and release into serum after treatment with bromobenzene, carbon tetrachloride, or N-nitrosodimethylamine. Biochem Pharmacol 1985;34:4239-244.
19. De Matteis F. Rapid loss of cytochrome P-450 and haem caused in the liver microsomes by the porphyrinogenic agent 2-allyl-2-isopropilacetamide. FEBS Lett 1970;6:343-45.
20. De Matteis F, Abbritti G, Gibbs AH. Decreased liver activity of porphyrin-metal chelatase in hepatic porphyria caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Studies in rats and mice. Biochem J 1973;134:717-27.
21. Hift RJ, Thunell S, Brun A. Drugs to porphyria: From observation to a modern algoritm-based system for the prediction o porphyrinogenicity. Pharmacol and Therap 2011;132:158-69.
22. Marver HS, Tscudy DP, Perlroth MJ, Collins A. Deltaaminolevulinic acid synthetase. I. Studies in liver homogenates. J Biol Chem 1966;241:2803-809.
23. Mauzerall D, Granick S. The occurrence and determination of 5-aminolevulinic acid and porphobilinogen in urine. J Biol Chem 1956;219:435-46.
24. Foucaud L, Goulaouic S, Bennasroune A, Laval-Gilly P, Brown D, Stone V, Falla J. Oxidative stress induction by nanoparticles in THP-1 cells with 4-HNE production: stress biomarker or oxidative stress signalling molecule? Toxicol In Vitro 2010;24:1512-520.
25. Cathcart R, Schwiers E, Ames BN. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay. Anal Biochem 1983;134:111-16.
26. Mohandas J, Marshall JJ, Duggin GG, Horvath JS, Tiller DJ. Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer. Cancer Res 1984;44:5086-91.
27. Haque R, Bin-Hafeez B, Parvez S, Pandey S, Sayeed I, Ali M, Raisuddin S. Aqueous extract of walnut (Juglans regia L.), protects mice against cyclophosphamide-induced biochemical toxicity. Hum Exp Toxicol 2003;22:473-80.
28. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968;25:192-205.
29. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969;27:502-22.
30. Anderson ME. Determination of glutathione and glutathione disulfide in biological samples. Meth Enzymol 1985;113:548-54.
31. Bottomley RH, Pitot HC, Potter VR, Morris HP. Metabolic adaptations in rat hepatomas: V. Reciprocal relationship between threonine dehydrase and glucose-6-phosphate dehydrogenase. Cancer Res 1963;23:400-09.
32. Zhang Z, Yu J, Stanton RC. A method for determination of pyridine nucleotides using a single extract. Anal Biochem 2000;285:163-67.
33. Lowry HO, Rosebrough RJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1995;193:265-75.
34. Lowry OH, Passonneau JV. A Flexible System of Enzymatic Analysis. New York: Academic Press, 1972.
35. Motulsky H. GraphPad Prism. Version 4.0. Statistcs Guide. Statistical Analysis for Laboratory and Clinical Researchers. San Diego, CA, USA: GraphPad Software Inc, 2005.
36. Bechara EJ. A free hypothesis of porphyria with 5-aminolevulinic acid overload. In: Davies KJA, Ursini F, eds. The Oxygen Paradox. Italy: CLEUP University Press, 1995:503-13.
37. Untucht-Grau R, Schirmer RH, Schirmer I, Krauth-Siegel RL. Glutathione reductase from human erythrocytes: amino-acid sequence of the structurally known FAD-binding domain. Eur J Biochem 1981;120:407-19.
38. Gutierrez-Correa J, Stoppani AO. Inactivation of yeast glutathione reductase by Fenton systems: effect of metal chelators, catecholamines and thiol compounds. Free Radic Res 1997;27:543-55.
39. Morgenstern R, Zhang J, Johansson K. Microsomal glutathione transferase 1: mechanism and functional roles. Drug Metab Rev 2001;43:300-06.
40. Van Ommen B, Ploemen JH, Ruven HJ, Vos RM, Bogaards JJ, van Berkel WJ, van Bladeren PJ. Studies on the active site of rat glutathione S-transferase isoenzyme 4-4. Chemical modification by tetrachloro-1,4-benzoquinone and its glutathione conjugate. Eur J Biochem 1989;181:423-29.
41. Johnson JA, Finn KA, Siegel FL. Tissue distribution of enzymic methylation of glutathione S-transferase and its effects on catalytic activity. Methylation of glutathione S-transferase 11-11 inhibits conjugating activity towards 1-chloro-2, 4-dinitrobenzene. Biochem J 1992;282:279-89.
42. Van Bladeren PJ, van Ommen B. The inhibition of glutathione S-transferases: mechanisms, toxic consequences and therapeutic benefits. Pharmacol Ther 1991;51:35-46.
43. Joron GE, Downing JB, Bensley EH. Poisoning by Sedormid (allyl-isopropyl-acetyl urea). Can Med Assoc J 1953;68:62-3.
44. Moore MR. An historical introduction to porphyrin and chlorophyll synthesis. In: Warren MJ, Smith AG, eds. Tetrapyrroles: Birth, Life and Death. New York: Springer Sciences Business Media, 2009:1-28.
45. Lelli SM, Mazzetti MB, San Martín de Viale LC. Hepatic alteration of tryptophan metabolism in an acute porphyria model its relation with gluconeogenic blockage. Biochem Pharmacol 2008;75:704-12.
46. Raza H. Dual localization of glutathione S-transferase in the cytosol and mitochondria: implications in oxidative stress, toxicity and disease. FEBS J 2011;278:4243-251.
47. Kleiman de Pisarev DL, Ferramola de Sancovich AM, Sancovich HA. Hepatic indices of thyroid status in rats treated with hexachlorobenzene. J Endocrinol Invest 1995;18:271-76.
48. Holzmann H, Denk R, Morsches B. Fermenthestimmungen in erythrocytcn von kranken mit porphyria cutanea tarda. Wien Klin Wschr 1969;47:112-14.
49. Rainer H, Schnack H, Moser K. Untersuchungen üher den erythrozytcnstoffwechscl hei patienten mit porphyria hepatica. Wien Klin Wschr 1970;82:853-65.
50. Markkanen T, Peltola O, Koskelo P. Pentose phosphate metabolism of erythrocytes in hepaticporphyrias. Acta Haematol 1971;46:142-48